Document is current

Any future updates will be listed below

Influence of continuous erythropoietin receptor activator (CERA) administration intervals on erythropoietic effect in hemodialysis patients

Crossref DOI link: https://doi.org/10.1186/S41100-016-0071-X

Published: 2016-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

About CrossMark